{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:08:34Z","timestamp":1783962514130,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL179089"],"award-info":[{"award-number":["R01HL179089"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL46716"],"award-info":[{"award-number":["R01HL46716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R56HL169501-01"],"award-info":[{"award-number":["1R56HL169501-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL176640-01"],"award-info":[{"award-number":["1R01HL176640-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL16051703"],"award-info":[{"award-number":["T32HL16051703"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL128831"],"award-info":[{"award-number":["R01HL128831"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mvr.2026.104956","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T22:21:49Z","timestamp":1777242109000},"page":"104956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Linagliptin enhances coronary microvascular function and collateralization in a large animal model of cardiometabolic syndrome"],"prefix":"10.1016","volume":"166","author":[{"given":"Kelsey C.","family":"Muir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghamsh","family":"Kanuparthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Hamze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.","family":"Sellke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mvr.2026.104956_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1530\/JOE-16-0096","article-title":"Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction","volume":"229","author":"Apaijai","year":"2016","journal-title":"J. Endocrinol."},{"issue":"9","key":"10.1016\/j.mvr.2026.104956_bb0010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.metabol.2013.04.010","article-title":"GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways","volume":"62","author":"Aronis","year":"2013","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.mvr.2026.104956_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-017-0544-4","article-title":"Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice","volume":"16","author":"Aroor","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.mvr.2026.104956_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00667","article-title":"Endothelial dysfunction and passive changes in the aorta and coronary arteries of diabetic db\/db mice","volume":"11","author":"Beck","year":"2020","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.mvr.2026.104956_bb0025","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.metabol.2014.04.002","article-title":"Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity","volume":"63","author":"Bostick","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.mvr.2026.104956_bb0030","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.2147\/JIR.S380285","article-title":"DPP4 as a potential candidate in cardiovascular disease","volume":"15","author":"Chen","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.mvr.2026.104956_bb0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI65344","article-title":"Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.mvr.2026.104956_bb0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/CIRCULATIONAHA.120.047574","article-title":"Endotheliopathy of obesity","volume":"142","author":"Cooke","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mvr.2026.104956_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001075","article-title":"Dipeptidyl-peptidase 4 inhibition and the vascular effects of glucagon-like peptide-1 and brain natriuretic peptide in the human forearm","volume":"3","author":"Devin","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.mvr.2026.104956_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacasi.2022.09.015","article-title":"Beneficial effects of dipeptidyl Peptidase-4 inhibitors on heart failure with preserved ejection fraction and diabetes","volume":"3","author":"Enzan","year":"2023","journal-title":"JACC Asia"},{"issue":"5","key":"10.1016\/j.mvr.2026.104956_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/dci15-0036","article-title":"DPP-4 inhibitors and heart failure: some reassurance, some uncertainty","volume":"39","author":"Filion","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mvr.2026.104956_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lfs.2016.03.052","article-title":"Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes","volume":"154","author":"Fiordaliso","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.mvr.2026.104956_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121648","article-title":"Dipeptidyl peptidase 4 inhibition rescues PKA-eNOS signaling and suppresses aortic hypercontractility in male rats with heart failure","volume":"323","author":"Fontes","year":"2023","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.mvr.2026.104956_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70156","article-title":"Sitagliptin, a DPP-4 inhibitor, effectively promotes the healing of diabetic foot ulcer: a randomized controlled trial","volume":"17","author":"Gao","year":"2025","journal-title":"J. Diabetes"},{"issue":"4","key":"10.1016\/j.mvr.2026.104956_bb0075","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.mvr.2026.104956_bb0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/11630900-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamics of linagliptin","volume":"51","author":"Graefe-Mody","year":"2012","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.mvr.2026.104956_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2024.100532","article-title":"Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemia","volume":"392","author":"Harris","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3\u20134","key":"10.1016\/j.mvr.2026.104956_bb0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10555-007-9094-7","article-title":"Tumour vascularization: sprouting angiogenesis and beyond","volume":"26","author":"Hillen","year":"2007","journal-title":"Cancer Metastasis Rev."},{"issue":"24","key":"10.1016\/j.mvr.2026.104956_bb0095","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011\u20132016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mvr.2026.104956_bb0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jphs.2017.11.006","article-title":"The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure","volume":"135","author":"Hirose","year":"2017","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.mvr.2026.104956_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","article-title":"Microvascular dysfunction in diabetes mellitus and Cardiometabolic disease","volume":"42","author":"Horton","year":"2021","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.mvr.2026.104956_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100868","article-title":"Cardiometabolic disease staging and major adverse cardiovascular event prediction in 2 prospective cohorts","volume":"3","author":"Howell","year":"2024","journal-title":"JACC. Adv."},{"issue":"5\u20136","key":"10.1016\/j.mvr.2026.104956_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"issue":"6","key":"10.1016\/j.mvr.2026.104956_bb0120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1113\/EP085108","article-title":"Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction","volume":"100","author":"Inthachai","year":"2015","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.mvr.2026.104956_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2025.109518","article-title":"Impaired contractile response of human peripheral arterioles to angiotensin II after cardiopulmonary bypass","volume":"186","author":"Kanuparthy","year":"2025","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.mvr.2026.104956_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60387-7","article-title":"Metabolomics and the pig model reveal aberrant cardiac energy metabolism in metabolic syndrome","volume":"10","author":"Karimi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mvr.2026.104956_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-014-0157-0","article-title":"DPP-4 inhibitor Linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure","volume":"13","author":"Koibuchi","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.mvr.2026.104956_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114799","article-title":"Dipeptidyl peptidase-4 inhibitor sitagliptin induces vasorelaxation via the activation of Kv channels and PKA","volume":"384","author":"Li","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.mvr.2026.104956_bb0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.mvr.2026.104956_bb0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jada.2008.12.023","article-title":"Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance","volume":"109","author":"Miller","year":"2009","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.mvr.2026.104956_bb0155","article-title":"A clinically relevant swine model of chronic myocardial ischemia by Ameroid constrictor placement with simultaneous perfusion mapping","volume":"224","author":"Muir","year":"2025","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.mvr.2026.104956_bb0160","article-title":"Terminal harvest procedure of a large animal model of chronic myocardial ischemia with hemodynamic characterization and perfusion analysis","volume":"222","author":"Muir","year":"2025","journal-title":"J. Vis. Exp."},{"issue":"6","key":"10.1016\/j.mvr.2026.104956_bb0165","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jtcvs.2025.04.017","article-title":"Linagliptin exerts a sex-specific effect on cardiac function, collateralization, and metabolism in a swine model of cardiometabolic disease","volume":"170","author":"Muir","year":"2025","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"9","key":"10.1016\/j.mvr.2026.104956_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245638","article-title":"Pixelwise H-score: a novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images","volume":"16","author":"Ram","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mvr.2026.104956_bb0175","doi-asserted-by":"crossref","first-page":"C972","DOI":"10.1152\/ajpcell.00246.2023","article-title":"Effects of dipeptidyl peptidase 4 inhibition on the endothelial control of the vascular tone","volume":"325","author":"Ribeiro-Silva","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.mvr.2026.104956_bb0180","article-title":"Lost in translation: the valley of death across preclinical and clinical divide \u2013 identification of problems and overcoming obstacles","volume":"4","author":"S","year":"2019","journal-title":"Transl. Med. Commun."},{"key":"10.1016\/j.mvr.2026.104956_bb0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vph.2015.08.011","article-title":"Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice","volume":"79","author":"Salim","year":"2016","journal-title":"Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.mvr.2026.104956_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2013.05.2659","article-title":"Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes","volume":"125","author":"Scheen","year":"2013","journal-title":"Postgrad. Med."},{"issue":"1\u20133","key":"10.1016\/j.mvr.2026.104956_bb0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vph.2011.03.001","article-title":"Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways","volume":"55","author":"Shah","year":"2011","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.mvr.2026.104956_bb0200","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jss.2024.09.065","article-title":"Sodium-glucose Cotransporter-2 inhibition normalizes metabolic derangements in the ischemic myocardium","volume":"303","author":"Stone","year":"2024","journal-title":"J. Surg. Res."},{"issue":"6","key":"10.1016\/j.mvr.2026.104956_bb0205","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3892\/ijmm.2016.2578","article-title":"Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-\u03baB\/I\u03baB\u03b1 system through the activation of AMP-activated protein kinase","volume":"37","author":"Tang","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"12","key":"10.1016\/j.mvr.2026.104956_bb0210","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/dom.12750","article-title":"Vascular effects of linagliptin in non-obese diabetic mice are glucose-independent and involve positive modulation of the endothelial nitric oxide synthase (eNOS)\/caveolin-1 (CAV-1) pathway","volume":"18","author":"Vellecco","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"9","key":"10.1016\/j.mvr.2026.104956_bb0215","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mvr.2026.104956_bb0220","doi-asserted-by":"crossref","first-page":"H696","DOI":"10.1152\/ajpheart.00502.2019","article-title":"Transmural variation in microvascular remodeling following percutaneous revascularization of a chronic coronary stenosis in swine","volume":"318","author":"Weil","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mvr.2026.104956_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.trsl.2018.10.006","article-title":"Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds","volume":"205","author":"Whittam","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.mvr.2026.104956_bb0230","article-title":"Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.mvr.2026.104956_bb0235","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00210-022-02279-3","article-title":"Cardiovascular protection by DPP-4 inhibitors in preclinical studies: an updated review of molecular mechanisms","volume":"395","author":"Zakaria","year":"2022","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286226000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286226000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:42:29Z","timestamp":1783960949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286226000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"alternative-id":["S0026286226000567"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2026.104956","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linagliptin enhances coronary microvascular function and collateralization in a large animal model of cardiometabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2026.104956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104956"}}